Greater Houston Healthconnect Uses InterSystems HealthShare® to Create Largest Known COVID-19 Outcomes Study
GHH has assembled a cohort of more than one million COVID-19 positive cases with all associated medical histories for outcomes...
News
Powell Recovery Center Chooses Netsmart: Advancing EHR Platform to Better Serve Public Health and Combat Opioid Crisis
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#BehavioralHealth--Powell Recovery Center, a leading substance abuse treatment provider in Baltimore has chosen Netsmart to advance their...
Hologic Expands its Omni® Hysteroscopy Offering in Europe
New Omni 30° hysteroscope, Omni Lok cervical seal and Omni 5 French seal provide increased flexibility to support physicians both...
Accenture Named a Leader in the IDC MarketScape: Worldwide Life Science R&D BPO Services 2021 Vendor Assessment
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has been named a Leader in life science research and development (R&D) and business process...
41% of UK employees say workplace has negatively impacted wellbeing during pandemic
Majority of employees feel worse when it comes to wellbeing compared to 2019, and 33% believe they will be tired...
AlzeCure Presents at Vator Healthcare Innovation Summit on October 7
STOCKHOLM, SE / ACCESSWIRE / September 30, 2021 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company...
Nomination Committee of XVIVO Perfusion AB (publ)
GOTHENBURG, SE / ACCESSWIRE / September 30, 2021 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)The following members have been appointed to XVIVO...
Cybeats Addresses the Electric Vehicle Security and Charging Station Markets; Relay Comments on Mandated Software Requirements for EV Manufacturing and Infrastructure via SBOM
Toronto, Ontario--(Newsfile Corp. - September 29, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the...
MedTech Innovator Names Alva Health as 2021 Global Competition Winner at The MedTech Conference
Startup Receives $350K Grand Prize for Real-Time, Wearable Stroke Monitor for Older Americans Living with High Stroke Risk LOS ANGELES...
Scientific Industries to Present at the Lytham Partners Fall 2021 Investor Conference
BOHEMIA, NY and PITTSBURGH, PA / ACCESSWIRE / September 29, 2021 / Scientific Industries, Inc. (OTCQB:SCND) announced today that it...
Promaxo Announces Financing Agreement with Kineo to Support Growth Plans
OAKLAND, Calif.--(BUSINESS WIRE)--Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced an asset...
CAGW Releases Issue Brief on the Dangers of Government-Run Healthcare
WASHINGTON--(BUSINESS WIRE)--#GovWaste--Today, Citizens Against Government Waste (CAGW) released a new Issue Brief, “Government-Run Healthcare Will Harm Patients and Eliminate Consumer...
UTILITY Therapeutics to Present Data at IDWeek 2021
LONDON, UK / ACCESSWIRE / September 29, 2021 / UTILITY therapeutics Ltd., a biotechnology company focused on the US development...
iZafe Group nominated to win the award Golden Pill 2021
STOCKHOLM, SE / ACCESSWIRE / September 29, 2021 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ.) announces that for the second...
All Endpoints Met in Hepion Pharmaceuticals’ Drug-Drug Interaction Study with CRV431
EDISON, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial...
Denali Therapeutics Announces Upcoming Presentations on EIF2B Activator DNL343 and RIPK1 Inhibitor SAR443820/DNL788 at the 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting
Denali to present results from Phase 1 healthy volunteer study of EIF2B activator DNL343Sanofi to present Phase 2 study plans...
Editas Medicine Announces Positive Initial Clinical Data from Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10
No serious adverse events or dose-limiting toxicities observed to date Efficacy signals in the mid-dose cohort provide initial support for...
TNFα-supplemented DL-4 culture system supports first-in-clinic Smart Immune ProTcell™ technology for immuno-deficient patients fighting cancers and infections
Rapid reset of immune system can provide marked benefits in clinical settings where patients are significantly immunocompromisedPARIS, Sept. 29, 2021...
Mountain Valley MD Holdings Announces Letter of Intent with Red White and Bloom Brands Inc.
TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA: 20MP)...
Enlivex to Present at Reuters Events’ Cell & Gene Therapy USA 2021
Nes-Ziona, Israel, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...